Answers are grounded in this paper and cite their sources.
Cyclic GMP-AMP synthase (cGAS) serves as a cytosolic DNA sensor that detects double-stranded DNA (dsDNA) and responds by producing 2'3'-cyclic GMP-AMP (cGAMP), which in turn initiates downstream signaling events that drive innate immune activation. Tight control of cGAS activity is required to preserve immune balance; however, the molecular factors that fine-tune its activation dynamics and protein stability are not yet fully understood. Here, we employed a residue-resolved photo-cross-linking approach coupled with quantitative proteomics to profile cGAS regulators, which uncovered the chaperonin TRiC subunit CCT2 as a previously unappreciated cGAS-associated factor. Functional analyses demonstrated that CCT2 attenuates cGAS-STING signaling by facilitating autophagy-mediated turnover of DNA-bound cGAS aggregates, thereby limiting the persistence of immunostimulatory cytosolic DNA signals and ensuring appropriate immune responses. Collectively, these findings demonstrate that site-specific protein photo-cross-linking provides a powerful means to interrogate protein-protein interactions and define CCT2 as a key negative modulator of cGAS, with implications for therapeutic modulation of antiviral immunity.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: